Scinopsis is Now Veristat

Mastering a global approach to solving the complexities of successful regulatory writing

Scinopsis is now a part of Veristat, allowing us to better serve your drug development and medical writing needs for clinical trial content and essential regulatory documentation.  

Have questions about the integration, the services you have been receiving from Scinopsis, or the new services now available to you from Veristat?  Complete the form and we will get back to you.  

How Can We Help You?

Learn More with These Resources

Case Study

Successful IND Submission Paves the Way for a Global ...


Veristat’s Most Downloaded Assets of 2023

Case Study

Agile Medical Writing Support for an NDA